Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.

about

Development of Serum DHCR24 Antibody as a Marker for Hepatocellular Carcinoma: The End of the Beginning.

Item

http://www.wikidata.org/entity/Q35948114

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@ast

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@en

type

Item

label

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@ast

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@en

prefLabel

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@ast

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@en

P1476

Development of Serum DHCR24 An ...... oma: The End of the Beginning.

@en

P2093

Anthony W H Chan

http://www.w3.org/2001/XMLSchema#string

Stephen L Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.

Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study

Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.

Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.

A predictive model for the development of hepatocellular carcinoma, liver failure, or liver transplantation for patients presenting to clinic with chronic hepatitis C.

Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy.

On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.

Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.

P304

497-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EBIOM.2015.05.020

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277089433

http://www.w3.org/2001/XMLSchema#string

P698

26288814

http://www.w3.org/2001/XMLSchema#string

P932

4534882

http://www.w3.org/2001/XMLSchema#string